Does ROSUVASTATIN\ROSUVASTATIN Cause Benign prostatic hyperplasia? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Benign prostatic hyperplasia have been filed in association with ROSUVASTATIN\ROSUVASTATIN. This represents 3.4% of all adverse event reports for ROSUVASTATIN\ROSUVASTATIN.
19
Reports of Benign prostatic hyperplasia with ROSUVASTATIN\ROSUVASTATIN
3.4%
of all ROSUVASTATIN\ROSUVASTATIN reports
0
Deaths
19
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From ROSUVASTATIN\ROSUVASTATIN?
Of the 19 reports, 19 (100.0%) required hospitalization.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN\ROSUVASTATIN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN\ROSUVASTATIN Cause?
Dyspnoea (79)
Asthma (77)
Pneumonia (52)
Acute kidney injury (50)
Wheezing (50)
Myalgia (48)
Drug hypersensitivity (46)
Fatigue (44)
Pain (44)
Rhabdomyolysis (43)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which ROSUVASTATIN\ROSUVASTATIN Alternatives Have Lower Benign prostatic hyperplasia Risk?
ROSUVASTATIN\ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN\ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN\ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN\ROSUVASTATIN vs ROXITHROMYCIN
ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB